Evidence map›Paper›PMID 17855573›Full record

ArticleJournal of clinical microbiology2007

Multiplexed reverse transcriptase PCR assay for identification of viral respiratory pathogens at the point of care.

Sonia E Létant, Josue I Ortiz, Lance F Bentley Tammero, James M Birch, Robert W Derlet, Stuart Cohen, Dannelle Manning, Mary T McBride

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Clinical and economical impact of multiplex respiratory virus assays.Diagnostic microbiology and infectious disease · 2013
    Review
  12. Article
  13. Pathogen chip for respiratory tract infections.Journal of clinical microbiology · 2013
    Article
  14. Article
  15. Article
  16. Viral agents causing lower respiratory tract infections in hospitalized children: evaluation of the Speed-Oligo® RSV assay for the detection of respiratory syncytial virus.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012
    Article
  17. Article
  18. Multiplex reverse transcription PCR Luminex assay for detection and quantitation of viral agents of gastroenteritis.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2011
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sonia E LétantLawrence Livermore National Laboratory, L-231, Livermore, CA 94550, USA. letant1@llnl.gov
Josue I Ortiz
Lance F Bentley Tammero
James M Birch
Robert W Derlet
Stuart Cohen
Dannelle Manning
Mary T McBride
Lawrence Livermore National Laboratory · USUniversity of California Davis Medical Center · US

Funding

A Multiplexed Diagnostic Platform for Bioagent DetectionU01AI061184 · NIAID · UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB · PI COLSTON, BILL W · 2004 to 2006
$3.0M
NIAID NIH HHS U01 AI061184
6 · The paper itself

Abstract

We have developed a nucleic acid-based assay that is rapid, sensitive, and specific and can be used for the simultaneous detection of five common human respiratory pathogens, including influenza virus A, influenza virus B, parainfluenza virus types 1 and 3, respiratory syncytial virus (RSV), and adenovirus groups B, C, and E. Typically, diagnosis on an unextracted clinical sample can be provided in less than 3 h, including sample collection, preparation, and processing, as well as data analysis. Such a multiplexed panel would enable rapid broad-spectrum pathogen testing on nasal swabs and therefore allow implementation of infection control measures and the timely administration of antiviral therapies. We present here a summary of the assay performance in terms of sensitivity and specificity. The limits of detection are provided for each targeted respiratory pathogen, and result comparisons were performed on clinical samples, our goal being to compare the sensitivity and specificity of the multiplexed assay to the combination of immunofluorescence and shell vial culture currently implemented at the University of California-Davis Medical Center hospital. Overall, the use of the multiplexed reverse transcription-PCR assay reduced the rate of false-negative results by 4% and reduced the rate of false-positive results by up to 10%. The assay correctly identified 99.3% of the clinical negatives and 97% of the adenovirus, 95% of the RSV, 92% of the influenza virus B, and 77% of the influenza virus A samples without any extraction performed on the clinical samples. The data also showed that extraction will be needed for parainfluenza virus, which was only identified correctly 24% of the time on unextracted samples.

Indexed as

Point-of-Care SystemsAdenoviridaeHumansInfluenza A virusInfluenza B virusParainfluenza Virus 1, HumanParainfluenza Virus 3, HumanRespiratory Syncytial Virus, HumanRespiratory Tract InfectionsReverse Transcriptase Polymerase Chain ReactionSensitivity and Specificity

Identifiers

PMID17855573
PMCPMC2168510
OpenAlexW2156167738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.